Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NTRK2, also known as TrkB (Tropomyosin receptor kinase B), is a membrane-bound receptor tyrosine kinase primarily involved in the development and function of the nervous system. It is activated by neurotrophins such as BDNF, NT-4, and NT-3, triggering downstream signaling cascades that promote neuronal survival, differentiation, synaptic plasticity, and axon/dendrite growth. Dysregulation of NTRK2 has been linked to obesity, mood disorders, and neurological diseases.
Ligand binding induces receptor dimerization and autophosphorylation, activating downstream signaling pathways (Ras-MAPK/ERK, PI3K-Akt, PLCγ).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain-derived Neurotrophic Factor Receptor TrkB (NTRK2).